The Helsinn Investment Fund focuses on privately-owned companies with early stage technologies in Cancer Supportive Care, Cancer Diagnostics and Cancer Therapeutics, among other areas close to Helsinn’s interests such as dermatology, metabolism and gastro-intestinal disease. These technologies range from biotech to pharma, medical devices and food supplements. As well as these investments, Hels...